Mitochondrial neurogastrointestinal encephalopathy disease
Last updated 20 Sept 2023
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
Mitochondrial neurogastrointestinal encephalopathy (MNGIE) disease is a condition that affects several parts of the body, particularly the digestive system and nervous system. The major features of MNGIE disease can appear anytime from infancy to adulthood, but signs and symptoms most often begin by age 20. The medical problems associated with this disorder worsen over time.
Video picks for Genetic conditionsVideo library
Description
Mitochondrial neurogastrointestinal encephalopathy (MNGIE) disease is a condition that affects several parts of the body, particularly the digestive system and nervous system. The major features of MNGIE disease can appear anytime from infancy to adulthood, but signs and symptoms most often begin by age 20. The medical problems associated with this disorder worsen over time.
Almost all people with MNGIE disease have a condition known as gastrointestinal dysmotility, in which the muscles and nerves of the digestive system do not move food through the digestive tract efficiently. The resulting digestive problems include feelings of fullness (satiety) after eating only a small amount, trouble swallowing (dysphagia), nausea and vomiting after eating, episodes of abdominal pain, diarrhea, and intestinal blockage. These gastrointestinal problems lead to extreme weight loss and reduced muscle mass (cachexia).
MNGIE disease is also characterised by abnormalities of the nervous system, although these tend to be milder than the gastrointestinal problems. Affected individuals experience tingling, numbness, and weakness in their limbs (peripheral neuropathy), particularly in the hands and feet. Additional neurological signs and symptoms can include droopy eyelids (ptosis), weakness of the muscles that control eye movement (ophthalmoplegia), and hearing loss. Leukoencephalopathy, which is the deterioration of a type of brain tissue known as white matter, is a hallmark of MNGIE disease. These changes in the brain can be seen with magnetic resonance imaging (MRI), though they usually do not cause symptoms in people with this disorder.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal recessive. More than one pattern can apply in different cases.
Related genes
Other names
MEPOP
Mitochondrial myopathy with sensorimotor polyneuropathy, ophthalmoplegia, and pseudo-obstruction
Mitochondrial neurogastrointestinal encephalopathy syndrome
MNGIE disease
MNGIE syndrome
Myoneurogastrointestinal encephalopathy syndrome
Oculogastrointestinal muscular dystrophy
OGIMD
POLIP
Polyneuropathy, ophthalmoplegia, leukoencephalopathy, and intestinal pseudo-obstruction
Thymidine phosphorylase deficiency
Patient picks for Genetic conditions

Digestive health
Coeliac disease
Coeliac disease (also spelled celiac disease) mainly affects the part of the gut called the small intestine. It can occur at any age. Coeliac disease is caused by a reaction of the gut to gluten. (For this reason it is sometimes also called gluten-sensitive enteropathy). Gluten is part of certain foods - mainly foods made from wheat, barley and rye. Various symptoms can develop including tummy (abdominal) pains, tiredness and weight loss. Symptoms go if you do not eat any foods that contain gluten.
by Dr Colin Tidy, MRCGP

Brain and nerves
Huntington's disease
Huntington's disease is a genetically inherited condition that causes parts of the brain and nervous system to stop working properly over time. It is a slowly progressive condition that interferes with the movements of your body, thinking and judgement, and can lead to a change in your behaviour. The symptoms occur because of damage and death of some of the brain cells (neurons) in particular parts of your brain. Genetic testing helps to diagnose Huntington's disease. At present there is no cure for Huntington's disease. Treatment is aimed at trying to control symptoms as much as possible when they develop.
by Dr Toni Hazell, FRCGP

Hormones
Addison's disease
Addison's disease is a condition in which your adrenal glands are not working as well as they should. In Addison's disease the adrenal glands do not produce as much of the steroid hormones (such as cortisol) as they normally do. These hormones are vital for your body and if you do not have enough of them, you can become very unwell. If the level of these hormones becomes very low, it can be life-threatening. Treatment is with replacement hormone tablets which you need to take every day.
by Dr Doug McKechnie, MRCGP

Heart health and blood vessels
Buerger's disease
Buerger's disease causes inflammation of blood vessels in the legs and arms, particularly in the hands and feet. It leads to narrowing and blockage of the blood vessels so that blood flow to the hands and feet is reduced. This causes pain and other symptoms. It may eventually lead to damage and death of the tissues in the hands and/or feet. The exact cause is not known. It mainly affects smokers but occasionally occurs in non-smokers. The single most important thing that you can do if you are diagnosed with Buerger's disease is to stop smoking. This can help to stop the disease from becoming worse and reduces your chance of needing surgical removal (amputation) of a finger, a toe, or worse.
by Dr Laurence Knott

Allergies, blood and immune system
Behçet's disease
Behçet's disease (also known as Behçet's syndrome) is a rare condition which causes frequent ulcers in your mouth and genital area and can affect different parts of your body. It most commonly affects your eyes and skin. It is more common in people from Mediterranean countries and also those from the Middle East and Eastern Asia. Various treatments are available which help reduce long-term complications.
by Dr Rosalyn Adleman, MRCGP

Heart health and blood vessels
Cardiovascular disease
Cardiovascular diseases (CVD) is a general term to describe diseases of the heart or blood vessels. The cause of most cardiovascular disease is a build-up of atheroma - a fatty deposit within the inside lining of arteries. The blood flow to the heart muscle may also be restricted by a blood clot in an artery taking blood to the heart muscle (coronary artery disease). Atheroma or a blood clot may also restrict or prevent blood going to the brain (cerebrovascular disease) or to the legs and feet (peripheral arterial disease). There are lifestyle factors that can be taken to reduce the risk of forming atheroma. These include not smoking; choosing healthy foods; a low salt intake; regular physical activity; keeping your weight and waist size down; drinking alcohol in moderation. Your blood pressure and cholesterol level are also important. All people aged over 40 years should have a cardiovascular health risk assessment - usually available at your GP surgery. If you have a high risk of developing a cardiovascular disease, treatment to reduce high blood pressure (hypertension) and/or cholesterol may be advised.
by Dr Colin Tidy, MRCGP
Related patient information and medicines

Patient information leaflet
Wilson's disease
Wilson's disease is a genetic disorder in which copper builds up in the body, mainly in the liver and brain. Without any treatment, the build-up of copper can cause serious symptoms. Treatment is with medication to remove the excess copper and/or to prevent a further build-up of copper. What is Wilson's disease. Wilson's disease is a condition.

Patient information leaflet
Coeliac disease
Coeliac disease (also spelled celiac disease) mainly affects the part of the gut called the small intestine. Coeliac disease is caused by a reaction of the gut to gluten. (For this reason it is sometimes also called gluten-sensitive enteropathy). Various symptoms can develop including tummy (abdominal) pains, tiredness and weight loss. What is.

Patient information leaflet
Huntington's disease
Huntington's disease is a genetically inherited condition that causes parts of the brain and nervous system to stop working properly over time. It is a slowly progressive condition that interferes with the movements of your body, thinking and judgement, and can lead to a change in your behaviour. The symptoms occur because of damage and death of.

Patient information leaflet
Addison's disease
Addison's disease is a condition in which your adrenal glands are not working as well as they should. In Addison's disease the adrenal glands do not produce as much of the steroid hormones (such as cortisol) as they normally do. What is Addison's disease. Addison's disease, also known as primary adrenal insufficiency, is a condition in which your.

Patient information leaflet
Buerger's disease
Buerger's disease causes inflammation of blood vessels in the legs and arms, particularly in the hands and feet. It leads to narrowing and blockage of the blood vessels so that blood flow to the hands and feet is reduced. It mainly affects smokers but occasionally occurs in non-smokers. The single most important thing that you can do if you are.

Patient information leaflet
Behçet's disease
Behçet's disease (also known as Behçet's syndrome) is a rare condition which causes frequent ulcers in your mouth and genital area and can affect different parts of your body. It most commonly affects your eyes and skin. It is more common in people from Mediterranean countries and also those from the Middle East and Eastern Asia. Various.
Further reading and references
- Mitochondrial neurogastrointestinal encephalopathy disease; MedlinePlus, National Library of Medicine.
- Hirano M, Marti R, Spinazzola A, Nishino I, Nishigaki Y. Thymidine phosphorylase deficiency causes MNGIE: an autosomal recessive mitochondrial disorder. Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1217-25. doi: 10.1081/NCN-200027485.
- Hirano M, Silvestri G, Blake DM, Lombes A, Minetti C, Bonilla E, Hays AP, Lovelace RE, Butler I, Bertorini TE, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology. 1994 Apr;44(4):721-7. doi: 10.1212/wnl.44.4.721.
- Hirano M. Mitochondrial Neurogastrointestinal Encephalopathy Disease. 2005 Apr 22 [updated 2016 Jan 14]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1179/
- Lara MC, Valentino ML, Torres-Torronteras J, Hirano M, Marti R. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): biochemical features and therapeutic approaches. Biosci Rep. 2007 Jun;27(1-3):151-63. doi: 10.1007/s10540-007-9043-2.
- Marti R, Spinazzola A, Nishino I, Andreu AL, Naini A, Tadesse S, Oliver JA, Hirano M. Mitochondrial neurogastrointestinal encephalomyopathy and thymidine metabolism: results and hypotheses. Mitochondrion. 2002 Nov;2(1-2):143-7. doi: 10.1016/s1567-7249(02)00036-3.
- Nishino I, Spinazzola A, Hirano M. MNGIE: from nuclear DNA to mitochondrial DNA. Neuromuscul Disord. 2001 Jan;11(1):7-10. doi: 10.1016/s0960-8966(00)00159-0.
- Nishino I, Spinazzola A, Papadimitriou A, Hammans S, Steiner I, Hahn CD, Connolly AM, Verloes A, Guimaraes J, Maillard I, Hamano H, Donati MA, Semrad CE, Russell JA, Andreu AL, Hadjigeorgiou GM, Vu TH, Tadesse S, Nygaard TG, Nonaka I, Hirano I, Bonilla E, Rowland LP, DiMauro S, Hirano M. Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations. Ann Neurol. 2000 Jun;47(6):792-800.
- Rajakulendran S, Pitceathly RD, Taanman JW, Costello H, Sweeney MG, Woodward CE, Jaunmuktane Z, Holton JL, Jacques TS, Harding BN, Fratter C, Hanna MG, Rahman S. A Clinical, Neuropathological and Genetic Study of Homozygous A467T POLG-Related Mitochondrial Disease. PLoS One. 2016 Jan 6;11(1):e0145500. doi: 10.1371/journal.pone.0145500. eCollection 2016.
- Teitelbaum JE, Berde CB, Nurko S, Buonomo C, Perez-Atayde AR, Fox VL. Diagnosis and management of MNGIE syndrome in children: case report and review of the literature. J Pediatr Gastroenterol Nutr. 2002 Sep;35(3):377-83. doi: 10.1097/00005176-200209000-00029.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

